Linezolid: its role in the treatment of gram-positive, drug-resistant bacterial infections.
暂无分享,去创建一个
[1] K. Bain,et al. Linezolid for the Treatment of Resistant Gram-Positive Cocci , 2001, The Annals of pharmacotherapy.
[2] E Rubinstein,et al. Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[3] L. G. Smith,et al. Oral antibiotic treatment of infectious diseases. , 2001, The Medical clinics of North America.
[4] C. Hawkes. Antibiotic resistance: a clinician's perspective. , 2000, Military medicine.
[5] D. L. Gilbert,et al. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions. , 2000, Journal of the American Pharmaceutical Association.
[6] M. Osterholm. Emerging infections--another warning. , 2000, The New England journal of medicine.
[7] J. Steckelberg,et al. Clinical aspects of antimicrobial resistance. , 2000, Mayo Clinic proceedings.
[8] R. Jones,et al. Oxazolidinones: a review. , 2000, Drugs.
[9] J. Chien,et al. Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] G. Kearns,et al. An update on the oxazolidinone antibiotics. , 1999, The Pediatric infectious disease journal.
[11] J. Steiner,et al. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. , 1997, JAMA.
[12] B Cookson,et al. Antibiotic resistance. Nosocomial gram-positive infection. , 1997, Journal of medical microbiology.